Search

Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a group of systemic small vasculitis characterized by ANCA positive in serum. Three diseases are included in this group of diseases: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). In China, standardized diagnosis and treatment of AAV is still lacking. Based on the evidence and guidelines from China and abroad, the Chinese Rheumatology Association formulated the standardization of diagnosis and treatment of ANCA associated vasculitis. The purpose is to standardize the diagnosis of AAV and disease activity assessment, and recommend the treatment strategies.抗中性粒细胞胞质抗体（ANCA）相关血管炎（AAV）是一组以血清中能检测到ANCA为最突出特点的系统性小血管炎。经典AAV包括肉芽肿性多血管炎、显微镜下多血管炎和嗜酸性肉芽肿性多血管炎。我国AAV的规范化诊断与治疗依然欠缺，中华医学会风湿病学分会在借鉴国内外诊治经验和指南的基础上，制定了本规范，旨在规范AAV的诊断与疾病活动度评估，对患者的治疗策略予以建议。.

In recent years, the clinical experts consensuses or guidelines of ankylosing spondylitis (AS)/spondyloarthritis (SpA) have been constantly updated, but to better understand and practice, patient self-participation management is one of the key points to improve the level of diagnosis and treatment. Through questionnaire survey of these patients, we screened out the most concerned issues, and established the AS/SpA patient practice guideline working group with multidisciplinary physicians and patients. Fifteen opinions, as the AS/SpA patient practice guidelines, are proposed in accordance with the relevant principles of the "WHO guidelines development manual" , and with the international normative process.近年来，强直性脊柱炎（AS）/脊柱关节炎（SpA）临床专家共识或指南不断更新，但如何更好地理解与执行，患者自我参与管理是提高诊疗水平的关键环节之一。通过成立多学科专家和患者共同参与的AS/SpA患者实践指南工作组，开展AS/SpA病友会患者与专家共同参与的AS/SpA患者关注问题的调查，筛选出问题，采用《世界卫生组织指南制订手册》相关原则，按照国际规范流程，提出AS/SpA患者实践指南意见15条。.

Hyperuricemia/gout is a common metabolic disease in China, which is a serious threat to people's health. In clinical practice, the standardization of prevention and diagnosis and the rate of treat-to-target need to be improved. There is still a lack of education for the patients about the understanding of clinical guidelines, the disease knowledge and the importance of cooperating with doctors to carry out diagnosis and treatment. From the most concerned issues of the patients, we established the hyperuricemia/gout patient practice guideline working group with multidisciplinary physicians and patients. Seventeen opinions, as the hyperuricemia/gout patient practice guidelines, are proposed in accordance with the relevant principles of the "WHO guidelines development manual" , and with the international normative process, aiming to improve the patients compliance, improve the level of health management of the disease.高尿酸血症/痛风是我国日趋递增的常见代谢性疾病，严重威胁人民健康。临床上，该病诊断的规范性及临床治疗达标率均有待提高，其中还欠缺针对患者对该病专家临床指南的理解、疾病知识普及和配合医生执行规范诊疗的重要性的教育。为此，从患者最关切的问题出发，成立多学科专家和患者共同参与的患者实践指南工作组，采用《世界卫生组织指南制订手册》相关原则，按照国际规范流程，提出高尿酸血症/痛风患者实践指南的意见17条，旨在提高患者诊治的依从性，提高该病健康管理水平。.

On the basis of clinical and laboratory data of 50 patients with adult onset Still's disease (AOSD), we strictly examined 4 diagnostic criteria adopted by different authors: criteria of Calabro, ARA, Medsger and Liu Gui-xin. Our result shows that Calabro's criteria has the best specificity (100%) and a higher diagnosis index (0.90) among the 4 criteria. Liu's criteria provides the best sensitivity (98%), but a lower specificity (86.9%) with a misdiagnosis rate of 14%. The rate of missed diagnosis with the ARA criteria is 35.7%. According to the present study, we recommend Liu's criteria for preliminary screen diagnosis, while Calabro's criteria for confirmation and differential diagnosis. Of special interest is that serum ferritin (SF) determination showed significantly higher level in 20 patients with AOSD (average 1194.5mg/L) than that in 19 patients with other rheumatic diseases (average 94mg/L, P0.001). AOSD patients with active disease have higher SF levels than patients with inactive disease (average 2742.9mg/L291.25mg/L, P0.001). So this test might be useful in diagnosis in AOSD and assessment of disease activity.